HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jovana J Ajduković Selected Research

androstane

1/2019Toward steroidal anticancer drugs: Non-parametric and 3D-QSAR modeling of 17-picolyl and 17-picolinylidene androstanes with antiproliferative activity on breast adenocarcinoma cells.
8/2018The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.
6/2018Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity.
12/2016Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
11/2015Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells.
10/2014Non-linear assessment of anticancer activity of 17-picolyl and 17-picolinylidene androstane derivatives--chemometric guidelines for further syntheses.
12/201317(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jovana J Ajduković Research Topics

Disease

5Neoplasms (Cancer)
11/2021 - 04/2015
4Prostatic Neoplasms (Prostate Cancer)
06/2018 - 12/2013
2Adenocarcinoma
01/2019 - 04/2015
2Lung Neoplasms (Lung Cancer)
08/2018 - 12/2016
2Colonic Neoplasms (Colon Cancer)
06/2018 - 04/2015
2Carcinoma (Carcinomatosis)
12/2016 - 04/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2018
1Necrosis
11/2015
1Breast Neoplasms (Breast Cancer)
11/2015
1Adenocarcinoma of Lung
04/2015

Drug/Important Bio-Agent (IBA)

7androstaneIBA
01/2019 - 12/2013
2SteroidsIBA
11/2021 - 06/2018
2AndrostanesIBA
01/2019 - 12/2013
2Durapatite (Hydroxylapatite)IBA
08/2018 - 12/2016
2ChitosanIBA
08/2018 - 12/2016
2Pharmaceutical PreparationsIBA
12/2016 - 12/2013
2Estrogen ReceptorsIBA
11/2015 - 04/2015
1LigandsIBA
01/2019
1PolymersIBA
08/2018
1EnzymesIBA
06/2018
1pyridineIBA
06/2018
1Aldo-Keto ReductasesIBA
06/2018
1propargylamineIBA
06/2018
1LactonesIBA
06/2018
1Coloring Agents (Dyes)IBA
12/2016
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
12/2016
1Trypan BlueFDA Link
12/2016
1compound 17IBA
04/2015
1Androgen Receptors (Androgen Receptor)IBA
10/2014
1abirateroneIBA
12/2013
1Aromatase (CYP19)IBA
12/2013

Therapy/Procedure

1Therapeutics
12/2016